Clinical Trials

36 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07201727 2025-10-01

CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

10 enrolled

Leukemia, Myeloid, Acute

NCT07144020 2025-08-27

Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

50 enrolled

Leukemia, Myeloid, Acute

NCT07126782 2025-08-17

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

10 enrolled

Leukemia, Myeloid, Acute

NCT03957915 2025-08-06

INA03

LymphoidOther hematologic neoplasm

33 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06980155 2025-05-20

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

60 enrolled

Leukemia, Myeloid, Acute

NCT01822015 2025-04-29

Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

55 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT04628338 2025-04-29

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

MyeloidOther hematologic neoplasm

8 enrolled

Graft vs Host Disease, Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06904859 2025-04-01

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

50 enrolled